ArticleiScience2023
Tivantinib alleviates inflammatory diseases by directly targeting NLRP3.
Yi Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleiScience2023
Yi Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.